PE Biosystems/Third Wave Technologies
This article was originally published in The Gray Sheet
Executive Summary
Termination of a January acquisition pact under which PE Biosystems would have acquired the Madison, Wisconsin-based developer of nucleic acid technologies for stock valued in the $300 mil. range will not prevent the firms from continuing to pursue joint collaborations, including several active projects, PE says (1"The Gray Sheet" Jan. 31, p. 19). "Recent discussions...led both companies to conclude that their collective interests would be best served if the companies remain independent but continue to collaborate," PE says in a May 25 release